This guide shows how single-domain antibodies can unlock crypitic epitopes, streamline CAR-T design, and sepped up the path to multispecific biologics.
Why VHH matters today
Camelid single-domain antibodies pack high affinity and exceptional stability into a footprint of about fifteen kilodaltons. They reach grooves that full IgGs cannot, tolerate harsh process conditions, and lend themselves to rapid genetic fusion.
Over the past decade VHH binders have moved from laboratory curiosity to clinical reality,…